InvestorsHub Logo

scottsmith

02/19/19 11:11 PM

#256661 RE: BonelessCat #256657

Mess with the bull and you get the horns. This is from January, 2018. Lol.

“The Company is now working to complete the Clinical Study Report (CSR). The CSR is central for engaging with the FDA to further discuss program development, and is also an important component for informing already advanced OM partnership discussions.”

http://www.ipharminc.com/press-release/2018/1/3/innovation-pharmaceuticals-brilacidin-meets-key-secondary-endpoint-in-phase-2-trial-delays-onset-of-severe-oral-mucositis-som?rq=Partnership